Luis E. Aguirre, MD

Foley Family Fellow in Leukemia @DanaFarber, @BrighamWomens via @MoffittNews | MPH (c) @HarvardChanSPH | Alum @ProgClinEffect, @ASH_hematology, IM @UmJmhIMRes

[Rami komrokji @Ramikomrokji]

I am so honored to be part of this journey as a senior clinical investigator and having presented the data to the ODAC FDA committee to get Imetelstat approved to hopefully help many of our MDS patients. ⁦⁦⁦@MoffittNews⁩ https://t.co/te8NSDFnug

[Rami komrokji @Ramikomrokji]

Our recent manuscript addressing Triple-Negative Myelofibrosis https://t.co/g4skBV6fdI great work by @LeafOnc @KuykendallMd @MoffittNews

[VJHemOnc @VJHemOnc]

Promising strides in #leukemia treatment from Jeffrey Lancet (@MoffittNews)!

Early findings from COVALENT-101 on BMF-219, a covalent menin inhibitor, show encouraging results in patients with relapsed/refractory #AcuteLeukemia

#ASH23 @ASH_hematology #Leusm

[Medscape Education @MedscapeCME]

❓ What's the latest in lower-risk myelodysplastic syndrome (LR-MDS) management? Join as Dr. @Ramikomrokji summarizes the latest data. #CME #MedEd #MedTwitter
🖥️ Take our activity here: https://t.co/wbADPZU8iJ

[Dr. Patrick Hwu @PatrickHwuMD]

Such an honor to witness the Graduate Medical Education graduation last night @MoffittNews! Congratulations to the more than 50 graduating fellows.

[Rami komrokji @Ramikomrokji]

@GhidaTalal @Dr_AmerZeidan @YaleCancer @YaleMed First and senior author are Jordanians 🙃 I told Amer to have the Jordanian Flag next to his name and mine .. we appreciate your endless support your highness .. proud moment for amer and I to lead development of next treatment in MDS

[Moffitt Cancer Center @MoffittNews]

LIVE from #ASCO23: Dr. Luis Aguirre’s (@LeafOnc) abstract on “Refining risk stratification in CMML: A comprehensive assessment of the IPSS-M and other molecularly informed models” is presented.

Learn more ➡️ https://t.co/lhRk2vAzgN

#ASCO23 #MoffittASCO23 @ASCO

[Moffitt Cancer Center @MoffittNews]

Dr. Luis Aguirre (@LeafOnc) joined President and CEO
@PatrickHwuMD at #ASCO23 for a discussion on refining risk stratification in CMML.

Learn more ➡️ https://t.co/YTrwTSFWQX

#MoffittASCO23 @ASCO

[Moffitt Cancer Center @MoffittNews]

Join Dr. Luis Aguirre (@LeafOnc) for a poster discussion on refining risk stratification in CMML at #ASCO23.

⏰: 6/5 from 11:30-1 p.m. CDT
📍: E450
Learn more ➡️ https://t.co/WXRYQ2BpH6

#MoffittASCO23 @ASCO

[Moffitt Cancer Center @MoffittNews]

#ASCO2023 | Moffitt's Dr. Rami Komrokjii discusses the results of a phase 3 clinical trial of Imetlestat, a telomerase inhibitor used for treating for both MDS and myelofibrosis. #MoffittASCO23 @ASCO

[Moffitt Hematology/Oncology Fellowship @MoffittHemOnc]

Many Congratulations to @MoffittHemOnc fellows @LeafOnc and James Yu for getting selected for @ConquerCancerFd @ASCO merit award! Can't wait to see you present your study results at #ASCO23 !!

[Rami komrokji @Ramikomrokji]

Honored I gave the Carol & John Bennett lecture marking 20 yr out of my training at UR & being recipient of their inaugural research award. A special treaty by Dr Bennett staying at their home. A legend and amazing mentor for whom I ll ever be in debt
@WilmotCancer @MoffittNews

[Moffitt Cancer Center @MoffittNews]

At the #MoffittScientifcSymposium, Dr. Luis Aguirre (@LeafOnc) discussed “Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes."

[Luis E. Aguirre, MD @LeafOnc]

@MoffittNews Thank you so much @MoffittNews for giving us the opportunity to share our research @Ramikomrokji! Honored to be part of this amazing group of people @MoffittHemOnc

[Moffitt Cancer Center @MoffittNews]

#HappeningNow | Dr. Luis Aguirre (@LeafOnc) presents on the “Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes” at the #MoffittScientifcSymposium.

[Rami komrokji @Ramikomrokji]

Our latest paper validating IPSS-M in one of the largest cohorts published in leukemia journal. Kudos to super fellow Luis Aguirre and the whole MDS team ⁦@LeafOnc⁩ ⁦@MoffittNews⁩ ⁦@MoffittResearch⁩ ⁦@md_padron⁩ https://t.co/vNEeQgJBhQ

[Somedeb Ball @drsomedeb]

It was fun taking part in this debate session w @LeafOnc and great talk on #MDSsm response criteria by @Dr_AmerZeidan and panel discussion @_MDEducation @Ramikomrokji @MoffittHemOnc @MoffittNews #MPNMDS US focus meeting 23

[Moffitt Hematology/Oncology Fellowship @MoffittHemOnc]

Congratulations on representing @MoffittHemOnc at the #MDSMPN US focus meeting debate stage! 👏👏

[Rami komrokji @Ramikomrokji]

Our latest paper providing first proof of principle. Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes https://t.co/iwzH9C9tUY

[Cancer Cell @Cancer_Cell]

Online Now: Metabolic programming and immune suppression in the tumor microenvironment https://t.co/kOSKYKxuVD